Dr Qamar Ghafoor

University Hospital Birmingham

Dr Qamar Ghafoor, is a Consultant Clinical Oncologist and Oncology Clinical Service Lead for University Hospital Birmingham. He instigated the extracranial SABR programme at UHB which is currently treating the highest number of NHS SABR CtE cases in the UK. He is PI for a number of clinical trials and the PROPEL radiotherapy database.

Dr Ghafoor is an Honorary Lecturer for the University of Birmingham, and has ongoing research focusing on breath-hold in lung cancer patients.

dont miss

Stereotactive Radiotherapy Treatment for Primary Lung Cancers, and Oligometastasis to the Lungs.

SABR is a commissioned, evidence based alternative to surgery for some early stage lung cancers, with the treatment intent being curative. Evidence from clinical trials, and real life UK experience via the CtE programme also shows benefits from treating oligometastasis to the lungs.


  • Anders Johnsson: Speaking at the Oncology Convention

    Anders Johnsson
    Scandinavian ChemoTech AB

    Dynamic-ElectroEnhanced Chemotherapy brings relief to palliative patients with a large tumour burden

  • Dr Shanmugasundaram Ramkumar: Speaking at the Oncology Convention

    Dr Shanmugasundaram Ramkumar
    University Hospital Southampton NHS Foundation Trust

    Radiotherapy developments in management of recurrent rectal cancers

  • Anita McWhirter: Speaking at the Oncology Convention

    Anita McWhirter
    The Royal Marsden NHS Foundation Trust

    Pan London SACT Verification Passport for Pharmacy

  • Tim Windle: Speaking at the Oncology Convention

    Tim Windle
    Prostate Cancer UK

    Why research isn’t enough for patient access: the technology appraisal process

  • Dr Tony Dhillon: Speaking at the Oncology Convention

    Dr Tony Dhillon
    University of Surrey and Royal Surrey County Hospital

    Immunotherapy and Colon Cancer